-
公开(公告)号:US20240392022A1
公开(公告)日:2024-11-28
申请号:US18671636
申请日:2024-05-22
Applicant: Genzyme Corporation
Inventor: Christine FARENC , Philippe TRUFFINET , Fabienne SCHUMACHER
Abstract: The present invention relates to treatment of relapsing forms of multiple sclerosis using an anti-human CD40L monoclonal antibody.